PHC Holdings Corporation Stock

Equities

6523

JP3801300009

Medical Equipment, Supplies & Distribution

Delayed Japan Exchange 09:07:18 2024-05-07 pm EDT 5-day change 1st Jan Change
1,170 JPY +0.52% Intraday chart for PHC Holdings Corporation +1.04% -18.51%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 350B 2.26B Sales 2025 * 349B 2.25B Capitalization 147B 947M
Net income 2024 * -6.66B -42.98M Net income 2025 * 9.75B 62.95M EV / Sales 2024 * 1.03 x
Net Debt 2024 * 213B 1.38B Net Debt 2025 * 198B 1.28B EV / Sales 2025 * 0.99 x
P/E ratio 2024 *
-22 x
P/E ratio 2025 *
15 x
Employees 9,403
Yield 2024 *
6.19%
Yield 2025 *
4.64%
Free-Float 21.51%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.60%
1 week+1.04%
Current month+2.72%
1 month+1.83%
3 months-22.24%
6 months-19.13%
Current year-18.51%
More quotes
1 week
1 150.00
Extreme 1150
1 176.00
1 month
1 081.00
Extreme 1081
1 180.00
Current year
1 081.00
Extreme 1081
1 549.00
1 year
1 081.00
Extreme 1081
1 650.00
3 years
1 081.00
Extreme 1081
3 120.00
5 years
1 081.00
Extreme 1081
3 120.00
10 years
1 081.00
Extreme 1081
3 120.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 21-05-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 21-05-31
Director/Board Member 61 21-09-02
Director/Board Member 63 13-07-31
More insiders
Date Price Change Volume
24-05-07 1,170 +0.52% 63 100
24-05-07 1,164 +0.09% 241,900
24-05-02 1,163 +0.35% 197,300
24-05-01 1,159 +1.67% 311,500

Delayed Quote Japan Exchange, May 07, 2024 at 09:07 pm EDT

More quotes
PHC Holdings Corp is a Japan-based company mainly engaged in the development, manufacture and sale of healthcare devices and services. The Company operates through three business segments. The Diabetes Management segment is involved in the development, manufacture and sale of in vitro diagnostic equipment such as self-monitoring blood glucose systems and point-of-care testing (POCT) products and electric drug injectors. The Healthcare Solutions segment is involved in the development and sale of medical information technology (IT) products such as receipt computers and electronic medical records, as well as the development of clinical laboratory diagnosis business. The Diagnostic and Life Science segment is involved in the development, manufacture and sale of research and medical support equipment, pathological diagnosis equipment, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
7
Last Close Price
1,164 JPY
Average target price
1,200 JPY
Spread / Average Target
+3.09%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW